DIRECTORS REPORT To,The Members,The board is pleased to present 23rd Annual Report on the business and operations of the Company together with The Audited Financial Statements (Standalone and Consolidated) for the financial year ended 31st March 2019. 1. COMPANY OVERVIEW: Your company is a vertically integrated Chemical company having presence in multiple speciality, Company is manufacturing whole range of Phase Transfer Catalyst (PTC) includes Quaternary Ammonium Compounds and Quaternary phosphonium Compounds. Company is having manufacturing facilities at Ankleshwar and Dahej and R&D center at Vadodara. Products are having wide range of application e.g. pharmaceutical intermediate, agro industries, surface active agent, cosmetics etc. 2. FINANCIAL RESULTS:A summary of the Company's financial results for the Financial Year 2018-19 is as under: ( ? in Lacs)Particulars | Standalone | Consolidated |
2018-19 | 2017-18 | 2018-19 | 2017-18 |
Net Revenue /Income | 20006.54 | 13421.35 | 20628.44 | 14024.27 |
Gross profit before interest and depreciation | 3283.21 | 2514.60 | 2992.40 | 2627.41 |
Finance Cost | 485.04 | 315.75 | 485.04 | 315.75 |
Profit before depreciation and amortization -(Cash Profit) | 2798.17 | 2198.85 | 2507.36 | 2311.66 |
Depreciation and amortization | 503.17 | 358.36 | 503.17 | 358.36 |
PBT before exceptional items | 2295.00 | 1840.49 | 2004.19 | 1953.30 |
Exceptional items | -72.12 | 2.23 | -72.12 | 2.23 |
Profit before Tax (PBT) | 2367.12 | 1838.26 | 2076.31 | 1951.06 |
Provision for Tax : Current | 453.24 | 529.40 | 514.18 | 533.41 |
Provision for Tax : Deferred | 111.16 | 117.69 | 111.16 | 117.69 |
Profit after Tax | 1802.72 | 1191.17 | 1450.97 | 1299.96 |
Exchange Rate as on 31/03/2018 1 USD = 65.0441 INRExchange Rate as on 31/03/2019 1 USD = 69.1713 INR 3. DIVIDEND:The Board of Directors of your Company after considering holistically the relevant circumstances has decided that it would be prudent, not to recommend any divided for the year under review. 4. TRANSFER TO RESERVES:The Board has decided to retain the entire amount of profits in the profit and loss account for the year under review 5. REVIEW OF BUSINESS ORERATIONS AND FUTURE PROSPECTS[A1] :Your Directors wish to present the details of Business Operations done during the year under review as under Pprofit before tax increased by 28.77% from Rs.1,838.26 lakhs in FY 2017-18 to Rs. 2,367.12 lakhs in FY 2018-19 due to efficient operations at Phase I and II at Dahej Unit-I.. Export Sales increased by 66.00% from Rs. 8399.31 lakhs during FY 2017-18 to Rs. 13943.10 lakhs during FY 2018-19. Domestic Sales increased by 29.69% over previous year from Rs. 4543.81 Lakhs to Rs. 5,892.98 Lakhs during the year under review. To reduce cost of Export Freight and Insurance and to expedite Export Deliveries, your company arranged warehouse facility in Netherlands and promoted wholly-owned subsidiary in USA under the name and style of TATVA CHINTAN USA, Inc. during FY 2016-17. Sales achieved from Netherlands warehouse amounted to Rs. 726.36 Lakhs during FY 2018-19 and by USA subsidiary amounted to Rs. 4470.02 Lakhs during FY 2018. The Export share in "Revenue from Operations" is 71.03% during FY 2018-19. The business continued to experience headwinds in demand generation from both global and domestic majors. The efforts on creating a diversified portfolio of innovative products, winning new customers and penetration into new markets is ongoing. The key emphasis of this business has been on investing in research and development, towards building a strong product portfolio in Quaternary, Hydroxides and Specialty chemicals. In order to widen market in Europe, wholly owned subsidiary has been established in the name and style of Tatva Chintan Europe B.V. in March, 2019. During the year the costs of key raw materials moved in mixed directions. The Company continued its strategy of importing raw materials from diverse sources and achieve in maintaining a steady price during the year. Some raw materials experienced strong inflationary trends exerting stress on the margins across product lines. FY 2018-19 saw volatility in USD-INR, ranging from Rs. 64.90 and Rs. 74.10, and averaging at 70.07. There was also significant volatility in exchange rates of emerging markets' currencies. Towards the end of the current fiscal it was around Rs. 69.1713. The exchange loss of Rs. 177 Lakhs is reported in Profit and Loss account during the year, which is on account of timing difference of foreign exchange revenue transactions and their realization and/or re-statement. Also, we have capitalized exchange loss of Rs. 39 Lakhs. Phase III of Unit I at Dahej SEZ. is currently under process and is expected to be completed in last quarter of FY 2019-20.The new capacity is expected to come on stream by last quarter of FY 2019-20. The expanded capacity will be utilized for the Company's growing export market. The investment in expansion of the capacity is based on customer inquiries and discussions and in anticipation of future research pipelines. The new capacity addition will be similar to the Company's existing multi-product plant configuration with multistage batch and products processing capabilities. The Company has reached out to markets in the US, Europe and Japan by having direct representations in those geographies, in addition to the strong presence of Tatva Chintan (USA) Inc. in USA. Through the year, the technology teams worked relentlessly to improve productivity, quality and costs of various products to offer a competitive marketing edge to the businesses on one hand and flexibility of sourcing to the supply chain team on the other. Continuous focus on improving operating efficiencies across manufacturing and supply chain applications, during the year, have helped the Company improve its margins and secure deeper penetration in the market. The top-line growth coupled with higher capacity utilization, helped in better absorption of overheads, contributing to improvements in the operating margins. Slack in high-margin products during second half resulted into reduction in overall operating margins for the fiscal. During the year a conservative inventory policy was followed in order to remain closer to the market prices of all the raw materials and access the resultant movement in the finished product prices. The receivables and inventories management have been an area of key management attention and are in line with the scope and scale of operations and the levels were well within acceptable industry norms. The Company is fully committed to its responsibilities in health, safety and environment (HSE) management and has continued to make sizeable investments in HSE during the year. 6. PERFORMANCE AND FINANCIAL POSITION OF EACH SUBSIDIARIES, ASSOCIATES AND JOINT VENTURE COMPANIES :The Consolidated Financial Statements of the Company are prepared in accordance with relevant Accounting Standards issued by the Institute of Chartered Accountants of India and forms an integral part of this Report.During the period under review, Tatva Chintan Europe B.V. was incorporated, which is yet to commence its business. A statement containing the salient features of financial statements of each of the subsidiaries, associates and joint venture companies in terms of provisions of Section 129(3) of the Companies Act, 2013 in the prescribed Form AOC- 1 is annexed ( Annexure -I) to this report and hence not repeated here for the sake of brevity. CHANGE IN NATURE OF BUSINESS, IF ANY:There is no change in the nature of business of the Company during the financial year under review.7. MATERIAL CHANGES AND COMMITMENT IF ANY AFFECTING THE FINANCIAL POSITION OF THE COMPANY OCCURRED BETWEEN THE END OF THE FINANCIAL YEAR TO WHICH THIS FINANCIAL STATEMENTS RELATE AND THE DATE OF THE REPORT:No material changes and commitments affecting the financial position of the Company occurred between the end of the financial year i.e. March 31, 2019 and the date of Directors' Report i.e. September 21,2019